These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis. Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015 [TBL] [Abstract][Full Text] [Related]
28. Variable Sequestration of Antifungals in an Extracorporeal Membrane Oxygenation Circuit. Lyster H; Pitt T; Maunz O; Diamond S; Roberts JA; Brown D; Mills J; Armstrong-James D; Gerovasili V; Carby M; Dunning J; Simon A; Reed A ASAIO J; 2023 Mar; 69(3):309-314. PubMed ID: 36731055 [TBL] [Abstract][Full Text] [Related]
29. Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19. Bertram R; Naumann HT; Bartsch V; Hitzl W; Kinzig M; Haarmeyer GS; Baumgärtel M; Geise A; Muschner D; Nentwich J; John S; Sörgel F; Steinmann J; Höhl R Mycoses; 2023 Dec; 66(12):1071-1078. PubMed ID: 37700457 [TBL] [Abstract][Full Text] [Related]
30. [Prognostic value of oxygen challenge test for patients with cardiogenic shock receiving extracorporeal membrane oxygenation]. Dong L; Zhang X; Liang F; Yu X; Yang T; Li L Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1102-1106. PubMed ID: 29216944 [TBL] [Abstract][Full Text] [Related]
31. Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support. Miller M; Kludjian G; Mohrien K; Morita K Am J Health Syst Pharm; 2022 Jul; 79(15):1245-1249. PubMed ID: 35377411 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study. Taher KW; Almofada R; Alomair S; Albassam AA; Alsultan A Paediatr Drugs; 2024 Mar; 26(2):197-203. PubMed ID: 38228969 [TBL] [Abstract][Full Text] [Related]
37. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit. Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO). Kois AK; Gluck JA; Nicolau DP; Kuti JL Int J Antimicrob Agents; 2022 Jul; 60(1):106603. PubMed ID: 35577257 [TBL] [Abstract][Full Text] [Related]
39. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study. Donadello K; Roberts JA; Cristallini S; Beumier M; Shekar K; Jacobs F; Belhaj A; Vincent JL; de Backer D; Taccone FS Crit Care; 2014 Nov; 18(6):632. PubMed ID: 25416535 [TBL] [Abstract][Full Text] [Related]
40. Population pharmacokinetic model-guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction. Lin XB; Lui KY; Guo PH; Liu XM; Liang T; Hu XG; Tong L; Wu JJ; Xia YZ; Chen P; Zhong GP; Chen X; Cai CJ Pharmacotherapy; 2022 Jan; 42(1):23-33. PubMed ID: 34655497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]